Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

Y0000087

Metronidazole impurity A

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

2-Methyl-4(5)-nitroimidazole

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C4H5N3O2
Numéro CAS:
696-23-1
Poids moléculaire :
127.10
Numéro Beilstein :
4032
Numéro MDL:
MFCD00151322
Code UNSPSC :
41116107
ID de substance PubChem :
329830836
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

metronidazole

Fabricant/nom de marque

EDQM

Pf

251-255 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

Cc1ncc([nH]1)[N+]([O-])=O

InChI

1S/C4H5N3O2/c1-3-5-2-4(6-3)7(8)9/h2H,1H3,(H,5,6)

Clé InChI

FFYTTYVSDVWNMY-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Metronidazole impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1050

Acide benzoique, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1052

Metronidazole, Pharmaceutical Secondary Standard; Certified Reference Material

1055002

Acide benzoique, United States Pharmacopeia (USP) Reference Standard

M1850000

Metronidazole, European Pharmacopoeia (EP) Reference Standard

M1851000

Metronidazole benzoate, European Pharmacopoeia (EP) Reference Standard

Y0001470

Acide benzoique, European Pharmacopoeia (EP) Reference Standard

1442009

Metronidazole, United States Pharmacopeia (USP) Reference Standard

1442100

Metronidazole benzoate, United States Pharmacopeia (USP) Reference Standard

BP603

Metronidazole, British Pharmacopoeia (BP) Reference Standard

BP244

2-Methyl-5-nitroimidazole, British Pharmacopoeia (BP) Reference Standard

BP735

Metronidazole benzoate, British Pharmacopoeia (BP) Reference Standard

PHR2165

Metronidazole Impurity F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2514

Metronidazole Impurity B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2512

Metronidazole Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Pictogrammes

Exclamation mark
GHS07

Mention d'avertissement

Warning

Mentions de danger

H302

Classification des risques

Acute Tox. 4 Oral

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 7

1 of 7

Metronidazole Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1052

Metronidazole

Metronidazole VETRANAL®, analytical standard

Supelco

46461

Metronidazole

vibrant-m

Y0000140

Ibuprofen impurity F

Paracetamol impurity J European Pharmacopoeia (EP) Reference Standard

Y0001945

Paracetamol impurity J

4-Nitroimidazole 97%

Sigma-Aldrich

141615

4-Nitroimidazole

Metronidazole BioXtra

Sigma-Aldrich

M1547

Metronidazole

Metronidazole analytical standard

Supelco

M3761

Metronidazole

G Carignan et al.
Food additives and contaminants, 8(4), 467-475 (1991-07-01)
An unidentified metabolite of dimetridazole (DMZ), found in pig plasma, muscle and kidney, was shown by chromatography and spectroscopy to be 2-methyl-5-nitroimidazole (2-MNI), resulting from N-demethylation of DMZ. This route of degradation competes with the oxidation pathway previously described. The
Fa-qing Ye et al.
Yao xue xue bao = Acta pharmaceutica Sinica, 40(2), 132-135 (2005-05-07)
To study the synthesis and antibacterial activity of ciprofloxacin derivatives. Ciprofloxacin derivatives were synthesized primarily from 2-methyl-5-nitroimidazol and ciprofloxacin through nucleophilic substitution. The antibacterial activity of the synthesized compounds were tested. Nine new compounds were synthesized. The structure of the
S Yang
Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 30(3), 345-346 (2002-09-06)
The 2-methyl-5(4)-nitromidazole(BH) is an ampholyte with acid and base. It is an intermediate of metronidazole. The amphoteric dissociation constant of BH determined by equimolar UV-spectrophotometry. The acidic dissociation constant pKa is 9.64 +/- 0.04 and the basic dissociation constant pKb
Daniel D Rossouw et al.
Nuclear medicine and biology, 32(4), 385-394 (2005-05-10)
The inflammation- and infection-seeking properties of (131)I-labeled ornidazole, a 5-nitroimidazole derivative, have recently been reported. Whole-body images in rabbits showed a more rapid uptake in inflamed areas compared to (67)Ga. In the present study, two novel (123)I-labeled 2-methyl-4-nitroimidazole derivatives were
Fa-qing Ye et al.
Yao xue xue bao = Acta pharmaceutica Sinica, 38(4), 260-263 (2003-08-02)
To study the synthesis and antibacterial activity of pyridonecarboxylic acid derivatives containing 2-methyl-5-nitroimidazol. Pyridonecarboxylic acid derivatives containing 2-methyl-5-nitroimidazol were synthesized primarily from 2-methyl-5-nitroimidazol, norfloxacin, ciprofloxacin, enoxacin via nucleophilic substitution and esterification. The antibacterial activity of the nine target compounds were
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique